First product order from PMI and first patient treated in Germany
22 January 2020 PolyNovo has received its first orders of BTM from PMI for use in Germany, Austria and Switzerland. The first orders for NovoSorb BTM were shipped to hospitals in preparation for the first surgery. PolyNovo is…
MTPConnect – Introducing Dr David Fox – Senior Director Sustainability
21 January 2020 MTPConnect is excited to announce the appointment of Dr David Fox as Senior Director of Sustainability starting today. David will be based in Newcastle, NSW and will work with Managing Director & CEO Dr Dan…
Bionic Vision Technologies Announces Interim Pilot Study Results of the BVT Bionic Eye System Designed to Help the Blind Achieve Greater Mobility and Independence
13 January 2020 Up to 44-Week Data Shows Significant Improvement in Both Obstacle Awareness and Object Detection Bionic Vision Technologies today announced the interim results of a pilot study involving four patients with late-stage Retinitis Pigmentosa (RP) implanted…
Two Million Dollar Month – PolyNovo Limited
7 January 2020 PolyNovo has said previously that it does not intend to issue quarterly financial statements. However, the Company would like to give shareholders a sense of the ramp up and direction of sales. Accordingly, we inform…
Gilead Sciences Announces the Appointment of Belinda Wood as new Senior Director of Government Affairs For Australia & NZ
13 January 2020 Gilead Sciences today announced the appointment of Belinda Wood as the new Senior Director of Government Affairs for Gilead Sciences in Australia and New Zealand (ANZ). In this role, Ms Wood will be responsible for…
Vaccinations shown to reduce flu mortality rates
9 January 2020 An Australian study has found an association between influenza vaccination and lowered mortality rates from the disease. An Australian study has confirmed flu vaccination effectively reduces mortality from the disease – positive news after a…
Researchers decipher a new way that immune cells detect infections and cancers
10 January 2020 MEDIA RELEASE Melbourne researchers have determined the molecular basis for how an important component of the immune system, called gamma-delta T cells, detects infections and cancers. Published today in Science, the research team from the Peter…
Human immune cells produced in a dish in world first
9 January 2020 A Melbourne research team has reproduced and visualised the earliest developmental steps in human immune cell production in the laboratory and are now set to advance our understanding of childhood diseases like leukemia and autoimmune…
Commencement of commercial-scale GMP extraction of medicinal cannabis resin
7 January 2020 Cann Group Limited (ASX: CAN) and IDT Australia Limited (ASX: IDT) have jointly announced that GMP extraction activities are underway for the first batches of medicinal cannabis resin. The extracted resin will be used as…
Potential risks when dating documents this year
10 January 2020 There has been talk in the media about the potential risks arising from the form of the new year: ‘2020’. The risk is that formatting the date as DD/MM/YY leaves the year column able to…
Five reasons we’re looking forward to the new decade
11 December 2019 By Anthony Farina, Chief Communications Officer and Vice President of Corporate Affairs Whether you call it the “twenty-tens” or the “teens,” the second decade of the 21st Century is drawing to a close. We’re saying farewell…
Opthea Completes Recruitment in Phase 2a Clinical Trial of OPT-302 for Diabetic Macular Edema
7 January 2020 Melbourne, Australia – Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel biologic therapies to treat eye diseases, has completed patient recruitment into the Company’s Phase 2a trial evaluating the safety and efficacy of…
